1.0009.09% ( -0.100 )
Closed: Oct 30, 16:00:00 (EDT)Current ValuationThe current P/E ratio is -0.54, above the reasonable range, cheaper than 19.16% of the time in the past 1 years, and the industry ranks 24/44, the industry Median -0.28.
-0.538xP/E
$1.00Stock price
$-1.86Earnings per share
-0.538xP/E
Stock price$1.00Earnings per share$-1.86
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -1.23x
- Typical range
- -2.25x–-0.59x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
016324864
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
BLCOUSBausch + Lomb | -64.35x | 102.62% | $7.14B |
MMEDUSMiniMed | -16.38x | 151.01% | $5.14B |
NEOGUSNeogen | -46.00x | 216.68% | $2.58B |
XRAYUSDentsply Sirona | -3.48x | 112.97% | $1.90B |
ESTAUSEstablishment Labs | -48.41x | 29.42% | $1.86B |
KIDSUSOrthopediatrics | -23.79x | 28.50% | $806.01M |
CERSUSCerus | -67.74x | 56.25% | $459.48M |
SMTIUSSanara Medtech | -9.42x | 104.59% | $301.64M |
OSURUSOraSure Tech | -5.53x | 35.64% | $271.74M |
RXSTUSRxSight | -4.31x | 0.66% | $202.56M |
ZTEKFUSZENTEK LTD | -5.29x | -- | $39.72M |
XTNTUSXtant Med | -3.53x | 477.77% | $39.31M |
TELAUSTela Bio | -0.88x | 15.66% | $36.37M |
RMTIUSRockwell Medical | -5.44x | 32.67% | $28.50M |
NSPRUSInspireMD | -0.40x | -- | $20.92M |
RVPUSRetractable Tech | -4.70x | -- | $16.91M |
CUPRUSCuprina | -3.44x | -- | $12.40M |
LUCYUSInnovative Eyewear | -0.94x | -- | $7.24M |
TUTHUSStandard Dental Labs Inc. | -3.17x | -- | $3.46M |
AIDXUS20/20 Biolabs | -0.38x | 44.74% | $2.72M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
